Výsledky vyhledávání - "Carmelo Giannitto Giorgio"

Fludarabine, Mitoxantrone and Dexamethasone as Front-line Therapy in Elderly Patients Affected by Newly-diagnosed, Low-grade Non-Hodgkin's Lymphomas with Unfavorable Prognostic Factors: Results of a Phase II Study

Autor: Giuseppe Novello, Placida Salice, Anna Maria Todaro, Stefano Cordio, Giuseppina Petralia, Carmelo Giannitto-Giorgio, Diego Serraino, Dario Giuffrida, Roberto Bordonaro, Maria Ursino, Francesco Marletta, Nunzio Restuccia, Mario Manusia

Publikováno v: Leukemia & Lymphoma. 45:93-100

About one-third of the cases of non-Hodgkin's lymphomas occur in patients aged 60 years or more. Nevertheless, there are very few data in the literature regarding the optimal therapeutic approach for both aggressive and indolent histologies. Fludarab

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d63b7a3e317e4e3f81e0eef0fdb099e6
https://doi.org/10.1080/1042819031000139765

Zobrazit plný text záznamu

A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer

Autor: Roberto Bordonaro, Concetto Scuderi, Antonio Russo, Nuccio Palermo, Alessandro Pappalardo, Franco Marletta, Giuseppe Bellissima, Carmelo Giannitto Giorgio, Sergio Castorina, Carmela Di Salvo, Daniele Santini, Carlo Di Rosa

The optimal management of unresectable locally advanced non-small-cell lung cancer in older patients has not been defined to date. The present phase II study was planned to evaluate the activity and safety of platinum-based induction chemotherapy fol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d545816c8383a17e6120c465163a3a9a
http://hdl.handle.net/20.500.11769/38410

Zobrazit plný text záznamu

Multicenter study of the eValuation of Eribulin (E) use in Sicily in metastatic breast cancer (MBC): A Prospective RegistrY (VESPRY trial)

Publikováno v: Annals of Oncology. 26:vi21

e12565 Background: Eribulin Mesylate is a non taxane microtubule dynamics inhibitor, approved for heavily-pretreated MBC patients (pts). Methods: This is a multicenter, prospective, single arm study for E-treatment of third line in pretreated MBC pts

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33efdba6acfe51974982876c7f180e10
https://doi.org/10.1093/annonc/mdv336.57

Zobrazit plný text záznamu

A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC)

Autor: Alessandro Pappalardo, Daniele Santini, Carmelo Giannitto Giorgio, Sergio Castorina, Giuseppe Failla, Dario Giuffrida, Giuseppina Petralia, Restuccia Nunzio, Antonio Russo, Roberto Bordonaro

Introduction: Lung cancer is the leading cause of tumour-related deaths in the elderly population but the optimal management of advanced NSCLC in older patients has not been defined to date. The present phase II study was planned to evaluate the effi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9516aab5c6ad3fc8f4b89b34ba782efa
http://hdl.handle.net/20.500.11769/51917

Zobrazit plný text záznamu

Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: phase II study

Autor: Sergio Castorina, Carmelo Giannitto Giorgio, Alessandro Pappalardo, Placida Salice, Giuseppe Failla, Antonio Russo, Giusy Blanco, Dario Giuffrida, Roberto Bordonaro, Daniele Santini

Introduction: The primary tumour type most likely to metastasize to the brain is lung cancer. In heavily pre-treated patients, limited therapeutic option is available and the results of availability therapies reported in literature are disappointing.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99f714087c3eb30a0d6b103404ac488f
http://hdl.handle.net/10447/32486

Zobrazit plný text záznamu

Activity and safety of CPBev regimen (cisplatinum, pemetrexed, and bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: Final results of a phase II study

Autor: Placida Salice, Hector Soto-parra, Roberto Bordonaro, Enrico Potenza, Stefano Cordio, Saverio Cinieri, Daniela Sambataro, Carmelo Giannitto-Giorgio, Concetta Sergi, F. Latteri, Giovanni L. Pappagallo

Publikováno v: Journal of Clinical Oncology. 30:e18026-e18026

e18026 Background: During the past five years the paradigms of advanced lung cancer therapy dramatically changed; Bevacizumab and Pemetrexed, when administered separately in association with platinum salts, demonstrated to improve survival in patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::12cc9f548d1a0eadd7d317ae181e34c9
https://doi.org/10.1200/jco.2012.30.15_suppl.e18026

Zobrazit plný text záznamu

P-214 Long-term remissions induced by oral temozolomide in progressive, pre-radiotherapy treated brain recurrences from non-small cell lung cancer

Autor: Salvatore Saita, Carmelo Giannitto-Giorgio, Placida Salice, Dario Giuffrida, Giuseppina Blanco, G. Lavenia, Stefano Cordio, Francesco Marletta, Roberto Bordonaro, Laura Di Dio

Publikováno v: Lung Cancer. 41:S145

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::129f53677f790b50cb295fcbc149bcb7
https://doi.org/10.1016/s0169-5002(03)92183-0

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání